Phreesia, Inc. (NYSE:PHR) CFO Sells $862,770.00 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 28,759 shares of Phreesia stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total transaction of $862,770.00. Following the sale, the chief financial officer now directly owns 116,174 shares of the company’s stock, valued at $3,485,220. This represents a 19.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Price Performance

Shares of PHR opened at $29.64 on Thursday. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The firm’s 50-day simple moving average is $27.14 and its two-hundred day simple moving average is $23.77. The stock has a market cap of $1.72 billion, a PE ratio of -20.16 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same quarter last year, the company earned ($0.58) EPS. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. Analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Trading of Phreesia

A number of institutional investors and hedge funds have recently bought and sold shares of the company. International Assets Investment Management LLC grew its holdings in shares of Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares during the last quarter. Arcadia Investment Management Corp MI lifted its stake in Phreesia by 9.5% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 97,085 shares of the company’s stock valued at $2,213,000 after acquiring an additional 8,460 shares during the period. TimesSquare Capital Management LLC boosted its holdings in Phreesia by 2.3% in the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after purchasing an additional 19,395 shares during the last quarter. Versor Investments LP bought a new position in shares of Phreesia during the 3rd quarter valued at $694,000. Finally, GSA Capital Partners LLP boosted its stake in shares of Phreesia by 418.3% in the 3rd quarter. GSA Capital Partners LLP now owns 49,553 shares of the company’s stock worth $1,129,000 after buying an additional 39,993 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

PHR has been the topic of several analyst reports. Citigroup lifted their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Robert W. Baird decreased their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research note on Friday, January 10th. Finally, KeyCorp increased their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. Thirteen analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia presently has a consensus rating of “Buy” and a consensus price target of $31.15.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.